Campbell; Michael G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Campbell; Michael G..The latest application filed is for "pyrazoles for the treatment of obesity and other cns disorders".

Company Profile

0.10.12

Campbell; Michael G. - Thunder Bay CA
Campbell; Michael G. - Sagamore Hills OH
Campbell; Michael G. - Sagamore Hill OH
Campbell, Michael G. - Durham NC
Campbell, Michael G. - Ottsville PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 8,129,424 - Bennani , et al. March 6, 2	2012-03-06
Pyrazoles for the treatment of obesity and other CNS disorders Grant 7,981,896 - Bennani , et al. July 19, 2	2011-07-19
Pyrazoles For The Treatment Of Obesity And Other Cns Disorders App 20110112088 - Bennani; Youssef L. ; et al.	2011-05-12
Indole Derivatives As Histamine 3 Receptor Inhibitors For The Treatment Of Cognitive And Sleep Disorders, Obesity And Other Cns Disorders App 20110059966 - Bennani; Youssef L. ; et al.	2011-03-10
Pyrazoles for the treatment of obesity and other CNS disorders Grant 7,897,634 - Bennani , et al. March 1, 2	2011-03-01
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 7,855,224 - Bennani , et al. December 21, 2	2010-12-21
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 7,528,262 - Bennani , et al. May 5, 2	2009-05-05
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders App 20090036446 - Bennani; Youssef L. ; et al.	2009-02-05
Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 7,319,103 - Bennani , et al. January 15, 2	2008-01-15
Pyrazoles for the treatment of obesity and other CNS disorders App 20070197526 - Bennani; Youssef L. ; et al.	2007-08-23
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders App 20070161676 - Bennani; Youssef L. ; et al.	2007-07-12
Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders App 20060009451 - Bennani; Youssef L. ; et al.	2006-01-12
Benzimidazole compounds for regulating IgE App 20050277686 - Sircar, Jagadish C. ; et al.	2005-12-15
Benzimidazole derivatives as modulators of IgE Grant 6,919,366 - Sircar , et al. July 19, 2	2005-07-19
Benzimidazole compounds for regulating IgE Grant 6,911,462 - Sircar , et al. June 28, 2	2005-06-28
Benzimidazole derivatives as modulators of IgE App 20050075343 - Sircar, Jagadish C. ; et al.	2005-04-07
Child's Handheld Digging Implement App 20030127871 - Campbell, Michael G.	2003-07-10
Benzimidazole compounds for regulating IgE App 20030100582 - Sircar, Jagadish C. ; et al.	2003-05-29
Benzimidazole derivatives as modulators of IgE App 20030004203 - Sircar, Jagadish C. ; et al.	2003-01-02
Benzimidazole analogs as down-regulators of IgE Grant 6,369,091 - Sircar , et al. April 9, 2	2002-04-09
Compounds having IgE affecting properties App 20020010343 - Sircar, Jagadish C. ; et al.	2002-01-24
Suppression of the IgE-dependent allergic response by benzimidazole analogs Grant 6,271,390 - Sircar , et al. August 7, 2	2001-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.